Results 151 to 160 of about 304,749 (335)

The 2024 Vasculitis Foundation Quality Care Summit: Seeking Strategies to Improve Care for All Patients

Arthritis &Rheumatology, Accepted Article.
Jason Springer, Elizabeth Brant, Anisha Dua, Jason Wadler, Dahlia Mak, Peter Merkel, Beth Westbrook, Joyce Kullman, Kevin Byram   +8 more
wiley   +1 more source

Education about deprescribing for pre‐licensed and licensed healthcare professionals: A scoping review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Deprescribing is complex because it involves patients' health, values, and preferences. The World Health Organization and Canadian Medication Appropriateness and Deprescribing Network have recommended that deprescribing be integrated into health curricula, prompting the need for further understanding about deprescribing education.
Brian J. Chow, Alexi M. Yuzwenko, Liz Dennett, Cheryl A. Sadowski   +3 more
wiley   +1 more source

The Relationship between Spiritual Well-being and Anxiety Levels in the Students of School of Nursing and Midwifery in Rafsanjan University of Medical Sciences in 2015

نشریه پرستاری ایران, 2017
Background & Aim: In modern societies, anxiety is one of the most common mental health problems. Nowadays, the attention of many religious psychologists has been drawn to the role of spiritual well-being in reducing mental disorders, including anxiety ...
N Rahimi, Z Asadolahi, A Afsharipour
doaj  

Gallipoli & Coniston: conflict, colonialism and spatial power [PDF]

, 2015
Goodall, Heather
core   +3 more sources

Implementation of mass pharmacogenetic testing: Dihydropyrimidine dehydrogenase testing prior to fluoropyrimidine treatment for patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Pharmacogenomics enables personalization of drug therapy improving effectiveness and/or safety. Dihydropyrimidine dehydrogenase [DPYD] testing prior to fluoropyrimidine chemotherapy was commissioned by NHS England in response to an update from the Medicines and Healthcare products Regulatory Agency.
Nisha Shaunak, Jessica Keen, Anna Kim, Munir Pirmohamed, William G. Newman, Paul J. Ross   +5 more
wiley   +1 more source

Appraising the visibility, relevance and impacts of clinical pharmacology

British Journal of Clinical Pharmacology, EarlyView.
Aims Clinical pharmacology (CP) used to be a strong medical and scientific field, but during the last three decades it seems to have lost some of its appeal. We reviewed the visibility, relevance and impact of CP and clinical pharmacologists across the globe and suggest ways to strengthen the discipline to address future pharmacotherapeutic challenges.
Serge Cremers, Samuel L. M. Arnold, Nilima A. Kshirsagar, Catriona Waitt, Olayinka O. Ogunleye, Lars L. Gustafsson   +5 more
wiley   +1 more source

Search Process Checklist [PDF]

, 2018
The Search Process Checklist is a tool that is used in instructional sessions with nurses in reference to evidence-based practice and literature searching. It is intended as a reference handout. It is under a creative commons license. If you would like a
Brown, Roy E.
core   +1 more source

Turkish translation and cultural adaptation of the Ascertaining Barriers to Compliance taxonomy for medication adherence

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this study was to create a Turkish version of the Ascertaining Barriers to Compliance (ABC) taxonomy for medication adherence. Methods A systematic literature search was conducted, followed by a national Delphi study using suggested methods of the International Society for Medication Adherence for translation of the ABC taxonomy for ...
Cansu Goncuoglu, Emre Kara, Cengizhan Ceylan, Pınar Ay, Mesut Sancar, Betul Okuyan   +5 more
wiley   +1 more source

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

British Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt, Áine Keogh, Linda Duane, John Ferguson, Anna Hobbins, Brian E. McGuire, Patrick Gillespie, Laurence J. Egan   +7 more
wiley   +1 more source

Assessment of Borderline Personality Disorder in Geriatric Institutions

Frontiers in Psychology, 2021
Franck Rexand-Galais, Lucas Pithon, Lucas Pithon, Lucas Pithon, Johane Le Goff, Johane Le Goff   +5 more
doaj   +1 more source